Healthy Extracts Reports Results for Third Quarter and Nine Months 2026
Key Highlights
- ➤Q3 net revenue $619,000, down 33% year over year
- ➤Nine-month revenue $4.3 million, up 53% to a record
- ➤Q3 net loss $1.7 million, versus $395,000 year-ago loss
- ➤Nine-month gross margin improved to 64.7% from 52.0%
- ➤Imaraïs Beauty products launched at 4,000 additional pharmacy locations nationwide
Expert Statements
Don Swanson, CEO of Healthy Extracts
“Our third quarter of 2026 represented another milestone period of new business development and market expansion as we continue to transform Healthy Extracts into a global provider of precision dosed gummies and other oral delivery systems. Our strong topline performance for the nine-month period reflects the continued evolution of our company into an industry leader in nutraceutical innovation. The integrations of Gummy USA and Imarais Beauty have provided a new foundation for accelerated growth, driven by expanded product lines and the broadening of our addressable markets. They have also introduced new major retailer customers in the U.S. and from around the world, resulting in significant B2B sales. While temporary inventory constrains limited our sales in the third quarter, we have continued to focus on our long-term strategic growth strategies. This includes achieving superior leadership in formulation and manufacturing technologies that target the high-growth, high-margin Nutra Pharma and Health & Beauty sectors. We expect these efforts to benefit from strong growth in the health and beauty sector which is expected to top $730 billion this year. Our acquisition of Imaraïs Beauty has also continued to deliver strong synergies with our Gummy USA operations. Their advanced formulations are unlike anything in the market today, and our precision dosing technology aligns perfectly with their long-standing dedication to premium quality, best-in-class innovation, and rapid global expansion. As we move through the final months of 2026 and prepare for the new year, we continue to expect Imaraïs' market reach and retail momentum to accelerate our in-house gummy manufacturing output. We believe we are at the beginning of a highly scalable, transformational growth phase for the entire company. By leveraging our advanced U.S. manufacturing capabilities, we see tremendous opportunities to expand our brand presence worldwide. This was demonstrated with the recent big win in Canada of one of the nation’s largest and longest-established pharmacy chains. We hope to soon release additional information on this major win. Given our many ongoing commercial initiatives, including new B2B customer engagements and product development, we still believe we have the potential to achieve an annualized net revenue run rate of more than 3x over last year. While this aspirational goal is aggressive, and dependent on market forces and certain customer timings outside of our control, we believe it is well supported by our sales pipeline and manufacturing and distribution capacity. We see our Gummy USA and Imaraïs Beauty merger deals reflecting a period of strengthening investor interest and consolidation within the gummy and wellness sector. Many other high-profile transactions, such as the $1.2 billion acquisition of Grüns Gummies by Unilever earlier this year, highlight the increasing market demand for scalable wellness brands-especially those with strong consumer engagement, differentiated product positioning, and growing retail distribution like ours. As we turn our sights to 2027, our mission remains clear: build one of the most trusted, innovative, and respected health, wellness and beauty companies in the world, and this delivering sustainable long-term value to our stakeholders. Thank you for joining us on this exciting journey and we appreciate your support as we work through the many high-reward challenges ahead.”
LAS VEGAS, NV / ACCESS Newswire / November 16, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical formulations and precision dose gummy manufacturing, reported results for the third quarter and nine months ended September 30, 2026. Financial comparisons are to the same year-ago period unless otherwise noted.
Financial Highlights * Net revenue for the third quarter totaled $619,000, declining 33%, with nine months revenue up 53% to a record $4.3 million. Third quarter 2026 revenue was reduced by a one-time promotional credit to new major pharmacy retailer customer of approximately $300,000, as well by temporary inventory constraints that limited planned customer shipments. Sequential quarterly growth is expected to return in the current fourth quarter, resulting in record revenues for the year. * Strong nine-month topline performance largely due to synergistic merger with Gummy USA™ in October 2025 and acquisition of Imaraïs Beauty in May of this year. Both added new product lines and B2B customers and expanded the company's distribution channels. * Gross profit in the third quarter totaled $339,000, down 24%, with nine months gross profit up 90% to $2.8 million. * Gross margin in the third quarter improved from 48.7% to 54.7%, with nine month's gross margin improving from 52.0% to 64.7%. * Net loss totaled $1.7 million or $(0.12) per basic and diluted share in the third quarter, compared to net loss of $395,000 or $(0.06) per basic and diluted share in the same year-ago quarter. Net loss for the nine months totaled $1.9 million or $(0.12) per basic and diluted share, compared to net loss of $727,000 or $(0.11) per basic and diluted share in the same year-ago period. The increases in net loss were largely due to increased interest expense, change in fair value of derivatives, and increased G&A expense related to the addition of Gummy USA and Imaraïs Beauty. This includes the buildup of approximately $200,000 in inventories in preparation for Imaraïs Beauty's accelerating U.S. and international expansion as well as the associated increase in manufacturing shifts. Q3 2026 Operational Highlights * Imaraïs Beauty products for health, wellness and beauty launched at an additional 4,000 pharmacy retail locations nationwide. The products' stylistic packaging has received prominent store shelf positioning on end-cap displays and are easy to find in the retailer's online store. The products include Imaraïs Beauty's most popular functional beauty and wellness gummies for skincare, haircare, gut health and overall wellness. The proprietary, clinically backed ‘ingestible beauty' formulations offer valuable health benefits and a unique consumer experience. * Continued focus on Imaraïs Beauty's broad distribution across major U.S. and international retail channels, including Target, Ulta Beauty, Nordstrom and Sprouts, as well as numerous international outlets. Leveraging Imaraïs Beauty's phenomenal success that has been featured in major business publications, including WWD, Forbes, Beauty Independent and Entrepreneur. * Healthy Extracts' transformative strategic merger with Gummy USA in October 2025 continued to address the large unmet need in the nutraceutical and pharmaceutical industry for precision-dosed gummy manufacturing technology, opening the door to new specialized B2B product development. This includes leveraging the FDA approval and certification received in April 2026 that enables Gummy USA to include controlled substances, like nicotine for smoking cessation, in future oral delivery products it may manufacture. The company believes this certification is unique to Gummy USA, providing a competitive edge. Management Commentary
Get started
Create a free account to read the full story.
